December 4, 2025 · Form 4 insider transaction
Diamond Robert E. Jr. bought 636,800 shares of Hyperliquid Strategies Inc., a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 8 days after the transaction.
On December 2, 2025, Hyperliquid Strategies Inc (the "Company") completed its previously announced business combination (the "Closing"), pursuant to the Business Combination Agreement, dated as of July 11, 2025 (as amended on September 22, 2025, the "BCA"), by and among the Company, Sonnet BioTherapeutics Holdings, Inc. ("Sonnet"), Rorschach I LLC, TBS Merger Sub Inc. and Rorschach Merger Sub, LLC . In connection with the Closing, Rorschach Capital LLC received an aggregate of 6,580,800 shares of common stock, par value $0.01 per share, of the Company (the "Common Stock"). On December 4, 2025, Rorschach Capital LLC distributed 636,800 shares of Common Stock to Mr. Diamond, a member of Rorschach Capital LLC.